Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial.
Álvaro Casas-Herrero, Mikel L Sáez de Asteasu, Iván Antón-Rodrigo...
https://pubmed.ncbi.nlm.nih.gov/35150086Actively Recruiting
Led by Pontificia Universidade Católica do Rio Grande do Sul · Updated on 2024-06-06
50
Participants Needed
4
Research Sites
17 weeks
Total Duration
P
Pontificia Universidade Católica do Rio Grande do Sul
Lead Sponsor
C
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Collaborating Sponsor
Researchers are evaluating the effects of a multicomponent physical exercise program called VIVIFRAIL® on the functional abilities of older adults aged 60 and above. This randomized, controlled, paired, single-blind clinical trial includes men and women enrolled in senior groups within a social assistance program. The study aims to examine how tailored exercises impact daily living activities, physical performance, fall risk, and overall health outcomes in this population. Participants are randomly assigned to two groups. The Intervention Group follows a personalized VIVIFRAIL® home exercise routine five times a week for six months, with sessions lasting 30 to 45 minutes and reassessments every six weeks. The Control Group receives healthy lifestyle guidance and exercise suggestions for three months, then begins the VIVIFRAIL® program for the following three months. Both groups are monitored throughout, with the total study period lasting around seven months. During the study, participants undergo evaluations including questionnaires on daily activities, physical performance batteries assessing strength, balance, and walking speed, and assessments of falls, health perception, and hospitalizations. Adherence is tracked through activity diaries and regular contact with researchers. The primary outcome measured is the short physical performance battery, with secondary measures covering various functional and health indicators. Monitoring continues through study completion, averaging one year from the start.
CONDITIONS
Effect of Multicomponent Exercises VIVIFRAIL® in Older Adults
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 7 months
Participants in the Intervention Group will perform home-based multicomponent exercises from the VIVIFRAIL® protocol five times a week, 30 to 45 minutes per session, for six months with a one-week break every six weeks for reassessment. Participants in the Control Group will receive exercise guidance for three months, then start the VIVIFRAIL® exercise program for three months.
Weekly visits or phone contacts for monitoring and reassessment every six weeks
Duration - Up to 1 year from study start
Participants continue activities and monitoring as assigned, with ongoing assessments of functional capacity and health outcomes.
Periodic assessments throughout the study
Total: 4 locations
1
Industrial Retirement and Pension Institute (IAPI)
Porto Alegre, Rio Grande do Sul, Brazil
Actively Recruiting
2
The First of May Community Center (CEPRIMA)
Porto Alegre, Rio Grande do Sul, Brazil
Actively Recruiting
3
The Older Adult Day Center (CDI)
Porto Alegre, Rio Grande do Sul, Brazil
Actively Recruiting
4
The Vila Floresta Community Center (CECOFLOR)
Porto Alegre, Rio Grande do Sul, Brazil
Actively Recruiting
A
Angelo Bós, Phd
A
Ana Paula Tiecker, MsC
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Álvaro Casas-Herrero, Mikel L Sáez de Asteasu, Iván Antón-Rodrigo...
https://pubmed.ncbi.nlm.nih.gov/35150086Alvaro Casas-Herrero, Ivan Anton-Rodrigo, Fabricio Zambom-Ferraresi...
https://pubmed.ncbi.nlm.nih.gov/31208471Eduardo L Cadore, Alvaro Casas-Herrero, Fabricio Zambom-Ferraresi...
https://pubmed.ncbi.nlm.nih.gov/24030238Nicolás Martínez-Velilla, Alvaro Casas-Herrero, Fabrício Zambom-Ferraresi...
https://pubmed.ncbi.nlm.nih.gov/26374430Juan Luis Sánchez-Sánchez, Philipe de Souto Barreto, Iván Antón-Rodrigo...
https://pubmed.ncbi.nlm.nih.gov/36580558Javier Courel-Ibáñez, Ángel Buendía-Romero, Jesús G Pallarés...
https://pubmed.ncbi.nlm.nih.gov/34197791Ofer Kis, Assaf Buch, Naftali Stern...
https://pubmed.ncbi.nlm.nih.gov/31301519Leocadio Rodriguez-Mañas, Linda P Fried
https://pubmed.ncbi.nlm.nih.gov/25468154M Izquierdo, R A Merchant, J E Morley...
https://pubmed.ncbi.nlm.nih.gov/34409961